|
García-Solano J, García-Solano ME, Torres-Moreno D, Carbonell P, Trujillo-Santos J, Pérez-Guillermo M, Conesa-Zamora P. Biomarkers for the identification of precursor polyps of colorectal serrated adenocarcinomas. Cell Oncol (Dordr). 2016 Jun;39(3):243-52. doi: 10.1007/s13402-016-0269-5. Epub 2016 Feb 1. PubMed PMID: 26832730.
AÑO: 2016; IF: 3.786
|
26832730
|
Tuomisto A, García-Solano J, Sirniö P, Väyrynen J, Pérez-Guillermo M, Mäkinen MJ, Conesa-Zamora P. HIF-1? expression and high microvessel density are characteristic features in serrated colorectal cancer. Virchows Arch. 2016 Oct;469(4):395-404. doi: 10.1007/s00428-016-1988-8. Epub 2016 Jul 15. PubMed PMID: 27421843.
AÑO: 2016; IF: 2.848
|
|
Vychytilova-Faltejskova P, Merhautova J, Machackova T, Gutierrez-Garcia I, Garcia-Solano J, Radova L, Brchnelova D, Slaba K, Svoboda M, Halamkova J, Demlova R, Kiss I, Vyzula R, Conesa-Zamora P, Slaby O. MiR-215-5p is a tumor suppressor in colorectal cancer targeting EGFR ligand epiregulin and its transcriptional inducer HOXB9. Oncogenesis. 2017 Dec 4;6(11):399. doi: 10.1038/s41389-017-0006-6. PubMed PMID: 29199273; PubMed Central PMCID: PMC5868056.
AÑO: 2017; IF: 4.722
|
|
García-Solano J, Turpin MC, Torres-Moreno D, Huertas-López F, Tuomisto A, Mäkinen MJ, Conesa A, Conesa-Zamora P. Two histologically colorectal carcinomas subsets from the serrated pathway show different methylome signatures and diagnostic biomarkers. Clin Epigenetics. 2018 Nov 9;10(1):141. doi: 10.1186/s13148-018-0571-3. PubMed PMID: 30413173; PubMed Central PMCID: PMC6230233.
AÑO: 2018; IF: 5.496
|
|
Garcia-Solano J, Turpin-Sevilla MDC, Garcia-Garcia F, Carbonell-Munoz R, Torres-Moreno D, Conesa A, Conesa-Zamora P. Differences in gene expression profiling and biomarkers between histological colorectal carcinoma subsets from the serrated pathway. Histopathology. 2019 Oct;75(4):496-507. doi: 10.1111/his.13889. Epub 2019 Aug 2. PubMed PMID: 31025430.
AÑO: 2019; IF: 3.626
|